GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » SenesTech Inc (NAS:SNES) » Definitions » Debt-to-EBITDA

SenesTech (SenesTech) Debt-to-EBITDA : -0.06 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is SenesTech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SenesTech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.25 Mil. SenesTech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.16 Mil. SenesTech's annualized EBITDA for the quarter that ended in Dec. 2023 was $-6.79 Mil. SenesTech's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SenesTech's Debt-to-EBITDA or its related term are showing as below:

SNES' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.49   Med: -0.07   Max: -0.02
Current: -0.05

During the past 10 years, the highest Debt-to-EBITDA Ratio of SenesTech was -0.02. The lowest was -0.49. And the median was -0.07.

SNES's Debt-to-EBITDA is ranked worse than
100% of 1211 companies
in the Chemicals industry
Industry Median: 2.28 vs SNES: -0.05

SenesTech Debt-to-EBITDA Historical Data

The historical data trend for SenesTech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenesTech Debt-to-EBITDA Chart

SenesTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.10 -0.19 -0.07 -0.04 -0.05

SenesTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.04 -0.04 -0.06

Competitive Comparison of SenesTech's Debt-to-EBITDA

For the Specialty Chemicals subindustry, SenesTech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SenesTech's Debt-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, SenesTech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SenesTech's Debt-to-EBITDA falls into.



SenesTech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SenesTech's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.25 + 0.156) / -7.571
=-0.05

SenesTech's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.25 + 0.156) / -6.792
=-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


SenesTech  (NAS:SNES) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SenesTech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SenesTech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SenesTech (SenesTech) Business Description

Traded in Other Exchanges
N/A
Address
23460 N 19th Avenue, Suite 110, Phoenix, AZ, USA, 85027
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.
Executives
Joel Lee Fruendt director, officer: Chief Executive Officer C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX AZ 85027
Grandinetti Phillip Nicholas Iii director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Kathleen Claire Kavanagh director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Jamie Bechtel Morrison director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Jacob Steven Leach director 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Delphine Francois Chiavarini director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Kenneth S Siegel director, officer: Chief Executive Officer 40 STARWOOD HOTELS & RESORTS, 111 WESTCHESTER AVE, WHITE PLAINS NY 10604
Nicole C Williams officer: Chief Strategy Officer 23460 N 19TH AVE SUITE 110, PHOENIX AZ 85027
Steven C. Krause officer: EVP, Sales and Marketing 23460 N. 19TH AVE STE 110, PHOENIX AZ 85027
Loretta Powers Mayer director, 10 percent owner, officer: CEO & Chief Scientific Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Cheryl Ann Dyer director, 10 percent owner, officer: Pres. & Chief Research Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Edward Albe officer: SVP of Commercialization 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 96004
Julia Ann Williams director C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Andrew Altman officer: Chief Operating Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Grover T Wickersham director, officer: Vice Chairman 430 CAMBRIDGE AVENUE, SUITE 100, PALO ALTO CA 94306